Advertisement

Topics

38 Fule Company Profile

05:04 EDT 26th September 2017 | BioPortfolio


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors.

In the present study, a new series of 2-[4-(pyrimidin-2-yl)piperazin-1-yl]-2-oxoethyl 4-substituted piperazine-1-carbodithioate derivatives (2a-n) were synthesized and screened for their monoamine oxi...

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Xi'an 38 Fule Health & Advisory, LTD

The Company serves as the sales and distribution arm of Shaanxi San Ba Fule Science & Technology, Ltd. ("Shaanxi San Ba"), which is owned by our Shareholders and Chief Executive Officer, wherein S...

38 Fule

More Information about "38 Fule" on BioPortfolio

We have published hundreds of 38 Fule news stories on BioPortfolio along with dozens of 38 Fule Clinical Trials and PubMed Articles about 38 Fule for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 38 Fule Companies in our database. You can also find out about relevant 38 Fule Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record